对保乳手术及预防性乳腺切除术的思考

鉴于对乳腺癌是全身性疾病的认识,为提高术后生存质量,目前乳腺癌治疗中保乳手术日益受到重视.而为了阻断高危险性的乳腺向乳腺癌发展,预防性乳房切除术也正在被患者接受.保留乳腺与预防性切除乳腺的医学实践反映了目前人们对乳腺癌的深层认识,值得深入思考.     

乳腺癌保乳手术的哲学思考

保乳手术基于乳腺癌是一种全身疾病的认识,符合医学发展的方向并最大程度地满足了患者对形体美的追求,保乳手术是早期乳腺癌手术的发展趋势,保乳治疗是多种疗法序贯应用的综合治疗。乳腺外科医师应及时转变治疗观念,以更大的责任心给予乳腺癌患者最好的治疗和更多的人文关爱。     

早产儿预防性应用抗生素的临床决策思路

近年来,随着对滥用抗生素所引起的细菌耐药性和二重感染的认识的逐步深入,预防性应用抗生素在临床上越来越受到限制。但由于早产儿感染的临床隐匿性和易并发严重并发症等特点,预防早产儿感染的发生和进一步的发展,就显得尤为重要。通过对早产儿发生感染的易感因素、感染诱因和临床特点的分析研究,来探讨早产儿临床预防应用抗生素的必要性、合理性及临床决策思路。     

The Prophylactic Mastectomy Dilemma: A Support Group for Women at High Genetic Risk for Breast Cancer

The goal of this pilot study was to test the usefulness of a six session psychoeducational support group for women at high genetic risk for breast cancer who were considering prophylactic mastectomy. The themes of the group sessions included overestimation of and anxiety about risk; desire for hard data; the emotional impact of watching a mother die of breast cancer; concerns about spouse reactions; self- and body image; the decision-making process; and confusion over whom to trust in decision making. Both the participants and the multidisciplinary leaders concluded that as a supplement to individual counseling, a support group is a beneficial and cost-effective treatment modality. Recommendations for the optimal format for such a group are described.     

重组人粒细胞集落刺激因子预防肿瘤化疗后Ⅲ度以上骨髓抑制的疗效分析

探讨重组人粒细胞集落刺激因子(rhG-CSF)对初诊晚期肿瘤患者化疗后骨髓抑制的合理预防用药时机.采用前瞻性随机方法,筛选首次化疗后出现Ⅲ度～Ⅳ度骨髓抑制的肿瘤患者,以化疗前24h内给予rhG-CSF的为预防治疗组;以化疗前未预防性给药为对照组,采用组间对照法,比较两组化疗后骨髓抑制的发生情况.结果发现两组的骨髓抑制发生率,预防组明显低于对照组,且Ⅲ度以上骨髓抑制发生率也明显降低.首次化疗后出现Ⅲ度～Ⅳ度骨髓抑制的肿瘤患者,下次化疗前24h内预防性给予rhG-CSF,能有效控制肿瘤化疗后骨髓抑制的发生,降低感染的风险,值得推广.     

早期乳腺癌患者术后心理状况研究

早期乳腺癌的检出率越来越高,关注治愈率同时,人们越来越关心患者术后的心理状态及生活质量.本文对保乳术及根治术后5年患者进行心理调查.保乳组患者术后心理障碍发生率明显低于根治组.保乳组患者术后心理状况影响因素主要为术后美容效果,而根治组患者心理障碍发生率与年龄、职业、家庭收入相关.两种手术方式对患者5年生存率及无病生存率的影响无明显差异,所以对于早期乳腺癌患者,在符合保乳原则的前提下,保乳手术是一种既安全又能提高生活质量的手术方式.     

Combined hysterectomy and mastectomy surgery for transgender patients in an integrated health care setting

Background: Hysterectomy and mastectomy surgery for gender affirmation have traditionally been performed as separate surgeries. Our institution offers these surgeries as a single combined procedure, typically with same-day discharge. Decreasing the number of times patients need to have surgery may reduce barriers to care by limiting surgical and hospital stay events. Our primary objective was to describe the perioperative experience of transgender patients who underwent combined hysterectomy and mastectomy surgery.

Methods: This retrospective case series assessed patients who underwent combined hysterectomy and mastectomy surgery between 2013 and 2015 in an integrated health care setting in the United States. Chart reviews were performed for outcomes of interest, which included operative and postoperative complications.

Results: We identified 25 patients who underwent a combined hysterectomy and mastectomy for the indication of gender transition. Preoperative patient characteristics included a median age of 31, with a median BMI of 25. Ninety-two percent of the patients were on testosterone therapy at the time of surgery. A total of 76% and 24% of patients had laparoscopic and vaginal hysterectomies, respectively. Intraoperatively, the average blood loss was 104 mL, and there were no complications. Eighty percent of patients were discharged on the same day. Postoperatively, 92% of patients experienced no major complications. One patient received a uterine artery embolization and blood transfusion for postoperative intraabdominal bleeding, and one patient presented 9 weeks after surgery with partial vaginal cuff dehiscence requiring a cuff revision. There were no re-admissions within six months of surgery. There were no major mastectomy-related complications.

Conclusions: Combined surgeries are feasible and reduce the number of surgical events and hospital stays. There were no complications that could be attributed to undergoing two procedures as a single incident.     

Complexities in Cancer Risk Counseling: Presentation of Three Cases

Complexities abound in the identification and management of families at increased risk for inherited forms of cancer. One of the ways to learn as a profession how best to provide cancer risk counseling (CRC) is to share counseling experiences. Such cases can provide insight into the issues raised by families and ways in which genetic counselors have handled complex situations. Here we describe three CRC cases initially presented at the 1995 American College of Medical Genetics meeting. The first case involves balancing the importance of informing a family of the presence of an inherited cancer syndrome with the family's right not to know. The second case illustrates the difficulties in assisting an individual to make medical management decisions in the face of uncertain risk information. The third case describes the complex interactions with a woman before and after her decision to have prophylactic surgery. (affiliated with Long Beach Memorial Breast Center at the time of counseling)     

The meaning of ‘reconstruction’ within the lived experience of mastectomy for breast cancer

This paper represents a heuristic study of the meaning and essence of ‘reconstruction’ within the lived experience of mastectomy for breast cancer. Open‐ended interviews were conducted with a sample of eight women aged 40 to 58 years, who underwent mastectomy for breast cancer. Four participants had immediate breast reconstruction; two participants had delayed breast reconstruction, and two participants decided not to have the procedure. The study demonstrates that themes of loss/change/reconstruction are inextricably linked to the experience of mastectomy. Loss of a breast was likened to bereavement and in some women caused a loss of part of their identity. The closeness of death altered the awareness the women had of their time left on earth. This awareness brought about change/reconstruction in the majority of the women, in their lives and in their relationships with others. Prior to breast reconstruction there is a place for exploring with women the meaning of ‘normal’ and ‘whole’. Implications for counselling are discussed.     

乳腺癌保乳术与根治术的比较

为了比较分析保乳术和根治术的治疗成本和对乳腺癌患者预后的影响,从2002年1月~2005年6月湘雅医院乳腺科的乳腺癌资料库中,随机抽取64例I~II期乳腺癌分为保乳治疗组(A组,32例)和根治术组(B组,32例),并随访。结果显示,A、B两组全部药品费用分别平均为32474.11±16126.00元、35107.30±19352.71元,总费用平均为53959.64±22033.28元、53382.10±24042.87元。两组药品费和总费用均无统计学差异(P=0.556、0.921)。中位随访时间30个月,两组病例均无局部复发。A、B组远处转移率分别为6.25%、9.38%,两组无明显差异(P=0.641);Kaplan-Meier生存分析表明A、B组生存率分别为96.88%、93.75%,两组无显著性差异(P=0.4566)。保乳术患者对残乳的满意率为90.61%,认为保留了乳房后其对家庭和社会生活仍充满自信的分别占75%和87.5%;相反,根治术者仅占28.13%和40.63%;A、B两组有显著性差异(P=0.000、0.000)。由此得出结论,保乳术和根治/改良根治术两种治疗方法对I~II期乳腺癌患者的预后无差异,成本亦无明显区别,而保乳术明显提高了患者的家庭、社会生活质量。